Guided Treatment in Optimal Selected Cancer Patients (GUTS)

Organisational unit: Research programme

  1. 2017
  2. Bekers, E. M., Groenen, P. J., Verdijk, M. A., Raaijmakers-van Geloof, W. L., Roepman, P., Vink, R., ... Flucke, U. (2017). Soft tissue angiofibroma: Clinicopathologic, immunohistochemical and molecular analysis of 14 cases. GENES CHROMOSOMES & CANCER, 56(10), 750-757. DOI: 10.1002/gcc.22478
  3. Raaphorst, R. M., Savolainen, H., Cantore, M., van de Steeg, E., van Waarde, A., Colabufo, N. A., ... Luurtsema, G. (2017). Comparison of in vitro assays in selecting radiotracers for in vivo P-glycoprotein PET imaging. Pharmaceuticals, 10, [10-0076]. DOI: 10.3390/ph10030076
  4. Brouwer, J. G., Makama, M., van Woudenbergh, G. J., Vasen, H. F., Nagengast, F. M., Kleibeuker, J. H., ... van Duijnhoven, F. J. (2017). Inflammatory potential of the diet and colorectal tumor risk in persons with Lynch syndrome. American Journal of Clinical Nutrition. DOI: 10.3945/ajcn.117.152900
  5. Sakata, M., Ishibashi, K., Imai, M., Wagatsuma, K., Ishii, K., Zhou, X., ... Toyohara, J. (2017). Initial Evaluation of a Novel Adenosine A2A Receptor Ligand, (11)C-Preladenant, in Healthy Human Subjects. Journal of Nuclear Medicine, 58(9), 1464-1470. DOI: 10.2967/jnumed.116.188474
  6. Vermeulen, M. A., Slaets, L., Cardoso, F., Giordano, S. H., Tryfonidis, K., van Diest, P. J., ... van Deurzen, C. H. M. (2017). Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. European Journal of Cancer, 82, 219-227. DOI: 10.1016/j.ejca.2017.01.034
  7. Lacas, B., Bourhis, J., Overgaard, J., Zhang, Q., Grégoire, V., Nankivell, M., ... MARCH Collaborative Group (2017). Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncology, 18(9), 1221-1237. DOI: 10.1016/S1470-2045(17)30458-8
  8. Strojan, P., Hutcheson, K. A., Eisbruch, A., Beitler, J. J., Langendijk, J. A., Lee, A. W. M., ... Ferlito, A. (2017). Treatment of late sequelae after radiotherapy for head and neck cancer. CANCER TREATMENT REVIEWS, 59, 79-92. DOI: 10.1016/j.ctrv.2017.07.003, 10.1016/j.ctrv.2017.07.003
  9. Berrington de Gonzalez, A., Vikram, B., Buchsbaum, J. C., de Vathaire, F., Dörr, W., Hass-Kogan, D., ... Kleinerman, R. A. (2017). A Clarion Call for Large-Scale Collaborative Studies of Pediatric Proton Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 98(5), 980-981. DOI: 10.1016/j.ijrobp.2017.03.033
  10. Gutierrez-Camino, A., Oosterom, N., den Hoed, M. A. H., Lopez-Lopez, E., Martin-Guerrero, I., Pluijm, S. M. F., ... van den Heuvel-Eibrink, M. M. (2017). The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia. PHARMACOGENETICS AND GENOMICS, 27(8), 303-306. DOI: 10.1097/FPC.0000000000000291
  11. Niemeijer, N. D., Rijken, J. A., Eijkelenkamp, K., van der Horst-Schrivers, A. N. A., Kerstens, M. N., Tops, C. M. J., ... Corssmit, E. P. M. (2017). The phenotype of SDHB germline mutation carriers: A nationwide study. European Journal of Endocrinology, 177(2), 115-125. DOI: 10.1530/EJE-17-0074
Previous 1 2 3 4 5 6 7 8 ...110 Next

ID: 37354